XML 18 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Equity, Noncontrolling Interests and Comprehensive Income
9 Months Ended
Sep. 30, 2011
Stockholders Equity Note [Abstract] 
Stockholders Equity Note Disclosure [Text Block]

Note 9 – Equity, Noncontrolling Interest and Comprehensive Income

The following table presents the changes in equity, noncontrolling interest and comprehensive income for the three and nine months ended September 30, 2011 and 2010:

            Accumulated         
      Capital in    Other         
   Common Excess of Retained Comprehensive Noncontrolling Comprehensive   
   Stock Par Value Earnings Income (Loss) Interest Income Total
Balance at June 30, 2011$12,823 $87,249 $158,998 $(5,507) $8,142    $261,705
 Net income 0  0  13,358     447 $13,805   
 Currency translation adjustments 0  0  0  (13,042)  (894)  (13,936)   
 Defined benefit retirement plans 0  0  0  (637)  0  (637)   
 Current period changes in fair value of derivatives 0  0  0  112  0  112   
 Unrealized loss on available-for-sale securities 0  0  0  (23)  0  (23)   
  Comprehensive loss                (679)  (679)
  Comprehensive income attributable to                    
   noncontrolling interest                447   
  Comprehensive loss attributable to                    
   Quaker Chemical Corporation               $(232)   
 Dividends ($0.24 per share) 0  0  (3,091)  0  0     (3,091)
 Share issuance and equity-based compensation plans 52  1,252  0  0  0     1,304
 Excess tax benefit from stock option exercises 0  (9)  0  0  0     (9)
Balance at September 30, 2011$12,875 $88,492 $169,265 $(19,097) $7,695    $259,230
                       
Balance at June 30, 2010$11,259 $32,798 $136,497 $(20,070) $6,063    $166,547
 Net income 0  0  6,340     517 $6,857   
 Currency translation adjustments 0  0  0  11,085  493  11,578   
 Defined benefit retirement plans 0  0  0  862  0  862   
 Current period changes in fair value of derivatives 0  0  0  191  0  191   
 Unrealized loss on available-for-sale securities 0  0  0  13  0  13   
  Comprehensive income                19,501  19,501
  Comprehensive loss attributable to                    
   noncontrolling interest                (1,010)   
  Comprehensive income attributable to                    
   Quaker Chemical Corporation               $18,491   
 Dividends ($0.235 per share) 0  0  (2,676)  0  0     (2,676)
 Share issuance and equity-based compensation plans 117  2,757  0  0  0     2,874
 Excess tax benefit from stock option exercises 0  176  0  0  0     176
Balance at September 30, 2010$11,376 $35,731 $140,161 $(7,919) $7,073    $186,422

            Accumulated         
      Capital in    Other         
   Common Excess of Retained Comprehensive Noncontrolling Comprehensive   
   Stock Par Value Earnings Income (Loss) Interest Income Total
Balance at December 31, 2010$11,492 $38,275 $144,347 $(13,736) $6,721    $187,099
 Net income 0  0  33,799  0  1,791 $35,590   
 Currency translation adjustments 0  0  0  (5,642)  (817)  (6,459)   
 Defined benefit retirement plans 0  0  0  12  0  12   
 Current period changes in fair value of derivatives 0  0  0  286  0  286   
 Unrealized gain on available-for-sale securities 0  0  0  (17)  0  (17)   
  Comprehensive income                29,412  29,412
  Comprehensive loss attributable to                    
   noncontrolling interest                (974)   
  Comprehensive income attributable to                    
   Quaker Chemical Corporation               $28,438   
 Dividends ($0.71 per share) 0  0  (8,881)  0  0     (8,881)
 Stock offering, net of related expenses 1,265  46,878  0  0  0     48,143
 Share issuance and equity-based compensation plans 118  3,186  0  0  0     3,304
 Excess tax benefit from stock option exercises 0  153  0  0  0     153
Balance at September 30, 2011$12,875 $88,492 $169,265 $(19,097) $7,695    $259,230
                       
Balance at December 31, 2009$11,086 $27,527 $123,140 $(10,439) $4,981    $156,295
 Net income 0  0  24,912     1,716 $26,628   
 Currency translation adjustments 0  0  0  629  376  1,005   
 Defined benefit retirement plans 0  0  0  1,400  0  1,400   
 Current period changes in fair value of derivatives 0  0  0  487  0  487   
 Unrealized loss on available-for-sale securities 0  0  0  4  0  4   
  Comprehensive income                29,524  29,524
  Comprehensive loss attributable to                    
   noncontrolling interest                (2,092)   
  Comprehensive income attributable to                    
   Quaker Chemical Corporation               $27,432   
 Dividends ($0.70 per share) 0  0  (7,891)  0  0     (7,891)
 Share issuance and equity-based compensation plans 290  5,910  0  0  0     6,200
 Excess tax benefit from stock option exercises 0  2,294  0  0  0     2,294
Balance at September 30, 2010$11,376 $35,731 $140,161 $(7,919) $7,073    $186,422

During the first nine months of 2011, the Company recorded $153 of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheet, related to stock option exercises. During the first nine months of 2010, the Company recorded $2,294 of these benefits. Prior to the first quarter of 2010, the Company's actual taxable income in affected jurisdictions was not sufficient to recognize these benefits, while the Company's full-year 2010 taxable income was sufficient to recognize these benefits. As a result, the Company recognized these benefits as a cash inflow from financing activities in its Condensed Consolidated Statement of Cash Flows which represents the Company's estimate of cash savings through September 30, 2011 and 2010, respectively.

The Company sold 1,265,000 shares of its common stock during the second quarter of 2011. The Company received proceeds of $48,143, net of related offering expenses, commissions and underwriting fees. The Company used the proceeds to repay a portion of its revolving credit line during the second quarter of 2011.